Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL GROUP STUDY OF THE EFFECT OF MELOXICAM IN MAINLAND CHINESE SUBJECTS WITH OSTEOARTHRITIS (OA) OF THE KNEE

NCT01430559 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01430559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01430559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL GROUP STUDY OF THE EFFECT OF MELOXICAM IN MAINLAND CHINESE SUBJECTS WITH OSTEOARTHRITIS (OA) OF THE KNEE
Lead sponsor
Pfizer
Phase
Not applicable
Overall status
Completed
Start date
October 24, 2011
Completion date
March 27, 2013
Enrollment
408 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee